A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.
…
continue reading
A Mayo Clinic podcast for laboratory professionals, physicians, and students, hosted by Justin Kreuter, M.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, featuring educational topics and insightful takeaways to apply in your practice.
…
continue reading
1
Get to Know the DLMP Chair: Eric Hsi, M.D.
12:13
12:13
Play later
Play later
Lists
Like
Liked
12:13
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Eric Hsi, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. Their discussion includes: Dr. Hsi’s experience in the field of pathology and what he is looking forward to workin…
…
continue reading
1
Breathing Easier: Immunotherapies for Asthma and Allergy
18:56
18:56
Play later
Play later
Lists
Like
Liked
18:56
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., interviews Douglas McMahon, M.D., from the Allergy and Asthma Center of Minnesota, to discuss how the lab supports asthma and allergy medical practice.By Mayo Clinic Laboratories
…
continue reading
1
New Panels Help Find Cause of Rapidly Progressive Dementia: Gregory (Gregg) Day, M.D.
24:17
24:17
Play later
Play later
Lists
Like
Liked
24:17
Rapidly progressive dementia covers many conditions, including Creutzfeldt-Jacob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' new evaluations help identify the cause of rapidly progressive dementia, to guide prognosis and treatment decisions. Show notes Speaker 3: (00:32) Can you provide a little background about…
…
continue reading
1
Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.
7:39
7:39
Play later
Play later
Lists
Like
Liked
7:39
Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate. (00:32) Can you tell us a little bit about yourself and your background? (01:46) Can you please provide an overview of laboratory testing for substance u…
…
continue reading
1
Lab Excellence: Spotlight on Laboratory Professionals
14:41
14:41
Play later
Play later
Lists
Like
Liked
14:41
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., interviews Eric Hsi, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, about the lab’s important role in healthcare. Timestamps: 00:00 Intro 00:42 Importance of labs in current medical practice 02:41 Understanding & apprecia…
…
continue reading
1
FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.
18:20
18:20
Play later
Play later
Lists
Like
Liked
18:20
In this special episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the final rule issued by the U.S. Food and Drug Administration (FDA) on April 29, 2024, to make explicit it…
…
continue reading
1
The Growing Crisis of Antimicrobial Resistance: Robin Patel, M.D.
8:18
8:18
Play later
Play later
Lists
Like
Liked
8:18
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Robin Patel, M.D.,director of the Infectious Diseases Research Laboratory and co-director of the Bacteriology Laboratory at Mayo Clinic. They discuss antimicrobial resistance and why it’s a major global heal…
…
continue reading
1
Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.
14:52
14:52
Play later
Play later
Lists
Like
Liked
14:52
David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood. (00:31) Could you please provide a little bit about yourself and your backg…
…
continue reading
1
Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D.
11:14
11:14
Play later
Play later
Lists
Like
Liked
11:14
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss testing innovations for Alzheimer’s disease and cognitive impairments, and how laboratorians can responsibly help s…
…
continue reading
1
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D
5:51
5:51
Play later
Play later
Lists
Like
Liked
5:51
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication. (00:32) Could you provide us with a little bit of …
…
continue reading
1
Exploring the Lab's Vital Role in Healthcare
18:07
18:07
Play later
Play later
Lists
Like
Liked
18:07
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Chancey Christenson, M.D., about the lab's important role in healthcare. Timestamps: 0:00 Intro 01:00 Why is it important to highlight the extensive presence of the laboratory in current medical practice? 05:20 What’s the story of how you first came to appreciate the e…
…
continue reading
1
Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.
11:08
11:08
Play later
Play later
Lists
Like
Liked
11:08
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss current events including Medical Laboratory Professionals Week, recent healthcare conferences, advocacy efforts, me…
…
continue reading
1
Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.
9:04
9:04
Play later
Play later
Lists
Like
Liked
9:04
Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's disease. (00:32) Do you mind giving the audience more information about yourself and your background? (01:53) C…
…
continue reading
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to discuss tick-borne diseases and the latest testing options. Specific topics of discussion include: The types of…
…
continue reading
1
Noninvasive plasma biomarker testing provides faster answers: Alicia Algeciras-Schimnich, Ph.D.
17:57
17:57
Play later
Play later
Lists
Like
Liked
17:57
Alicia Algeciras-Schimnich, Ph.D., discusses how Mayo Clinic Laboratories’ new noninvasive blood test for Alzheimer’s disease identifies the p-tau217 biomarker, which is associated with the accumulation of amyloid beta in the brain. Positive test results can facilitate access to disease-modifying therapies. (00:32): Dr. Algeciras, could you just pr…
…
continue reading
1
Drawing the Line: The Rationale Behind Blood Tube Collection Order
20:13
20:13
Play later
Play later
Lists
Like
Liked
20:13
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Brooke Katzman, Ph.D., to discuss the blood tube collection order. Show Notes: 0:00 Intro 0:41 Rational of blood tube order 3:15 Direct and indirect contamination 4:58 Draw order 8:11 Serum vs. Plasma 10:23 Testing for specific analytes 12:39 Interferences 14:38 Teachi…
…
continue reading
1
Dengue Outbreaks and Advancements in Colon Cancer Screening: Bill Morice, M.D., Ph.D.
11:07
11:07
Play later
Play later
Lists
Like
Liked
11:07
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss current events including dengue outbreaks, new colon cancer screening technology, and insurance coverage of innovat…
…
continue reading
1
Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.
8:26
8:26
Play later
Play later
Lists
Like
Liked
8:26
Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing. (00:33) Do you mind giving us a brief introduction of yourself and what you do at Mayo? (01:45) Can you tell us …
…
continue reading
1
Why Measles Is on the Rise: Matthew Binnicker, Ph.D.
15:52
15:52
Play later
Play later
Lists
Like
Liked
15:52
The Centers for Disease Control and Prevention (CDC) issued a recent health advisory in response to the increasing number of measles outbreaks in the United States. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of lab…
…
continue reading
1
Targeted panel boosts accuracy of hereditary pancreatitis testing: Experts: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.
10:24
10:24
Play later
Play later
Lists
Like
Liked
10:24
Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test results can guide cancer monitoring for patients and their families. (00:33) Dr. Hasadsri, can you tell the audience…
…
continue reading
1
Industry Updates From the Nation’s Capital: Bill Morice, M.D., Ph.D.
13:03
13:03
Play later
Play later
Lists
Like
Liked
13:03
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss important industry updates and legislative insights gathered from Dr. Morice’s recent trip to Washington, D.C. Thei…
…
continue reading
1
Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC
18:35
18:35
Play later
Play later
Lists
Like
Liked
18:35
Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide cancer surveillance for patients and their families. (00:32) Would each of you share a little bit about yourselves and your background? Dr. Sh…
…
continue reading
1
The Bullet Catch and Other Deadly Illusions!
17:47
17:47
Play later
Play later
Lists
Like
Liked
17:47
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Reade Quinton, M.D., assistant professor of laboratory medicine and pathology, to discuss a popular topic at this year’s 9th Annual Forensic Science Symposium, the bullet catch and other deadly illusions. Timestamps: 0:00 Introduction 0:45 Forensic Science Symposium di…
…
continue reading
1
Syphilis Testing Updates: Elitza Theel, Ph.D.
19:07
19:07
Play later
Play later
Lists
Like
Liked
19:07
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to follow up on the syphilis epidemic and discuss updated testing recommendations. Specific topics of discussion i…
…
continue reading
1
Testing aids nicotine-use cessation: Paul Jannetto, Ph.D.
9:51
9:51
Play later
Play later
Lists
Like
Liked
9:51
Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients in substance-use cessation programs and other settings. The serum and urine tests quantify nicotine and various metabolites. (00:32) Can you tell us a little bit about yourself and your background? (01:42) Can you please provide an overview of substance …
…
continue reading
1
Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D.
10:37
10:37
Play later
Play later
Lists
Like
Liked
10:37
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the Food and Drug Administration’s (FDA) progress on making a final rule around regulating laboratory-developed tes…
…
continue reading
1
Maximizing Impact Through Admin-Lab Collaboration
17:05
17:05
Play later
Play later
Lists
Like
Liked
17:05
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with operations administrator Mark Brown to discuss the significance of collaborating with administrators. Show notes: 0:00 Intro 0:59 Importance of working with lab administrators 3:00 Role of administrators 10:20 Resetting with admins 14:20 Supporting wellbeing…
…
continue reading
1
Black History Month: Bill Morice, M.D., Ph.D.
8:31
8:31
Play later
Play later
Lists
Like
Liked
8:31
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to honor Black History Month. They reflect on important advancements in healthcare and laboratory medicine that were led by Blac…
…
continue reading
1
Adrenal Gland Tumors: Stefan Grebe, M.D., Ph.D., and Irina Bancos, M.D.
13:18
13:18
Play later
Play later
Lists
Like
Liked
13:18
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Stefan Grebe, M.D., Ph.D., co-director of the Clinical Mass Spectrometry and Test Development Laboratory in the Department of Laboratory Medicine and Pathology, and Irina Bancos, M.D.,consultant in the Divis…
…
continue reading
1
Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D.
12:36
12:36
Play later
Play later
Lists
Like
Liked
12:36
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy for patients, who might be as young as age 2. (00:32) Could you please tell us a little bit about your backgroun…
…
continue reading
1
Charting the Course: The Journey to Becoming a Physician-Scientist
24:04
24:04
Play later
Play later
Lists
Like
Liked
24:04
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Alfredo Quinones-Hinojosa, M.D., a neurosurgeon and scientist at Mayo Clinic. From humble beginnings as a migrant worker, his story is one of resilience, determination, and a relentless pursuit of knowledge. Timestamps: 0:00 Introduction 1:54 Importance for physicians …
…
continue reading
1
Emerging and Reemerging Diseases: Bill Morice, M.D., Ph.D.
11:13
11:13
Play later
Play later
Lists
Like
Liked
11:13
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss current activity of infectious diseases. Their discussion includes: Vector-borne diseases that are causing public hea…
…
continue reading
1
Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D.
16:32
16:32
Play later
Play later
Lists
Like
Liked
16:32
Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune liver disease. (00:32) Could you please provide a little information about your background? (02:09) Please gi…
…
continue reading
1
Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.
17:59
17:59
Play later
Play later
Lists
Like
Liked
17:59
David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler test ordering. (00:32) Could you provide us with a litt…
…
continue reading
1
Recruiting for Careers in Laboratory Medicine
18:05
18:05
Play later
Play later
Lists
Like
Liked
18:05
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with placement coordinator Jamie Herget to discuss recruitment initiatives within the laboratory profession. Timestamps: 0:00 Introduction 0:59 Importance of recruitment 2:57 What roles are being recruited? 5:31 Effective strategies for recruitment 9:28 Ineffective strategi…
…
continue reading
1
The Pulse on Global Diagnostics: Bill Morice, M.D., Ph.D.
11:09
11:09
Play later
Play later
Lists
Like
Liked
11:09
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss what companies in the healthcare and diagnostics industries are focusing on in 2024. Their discussion includes: Insig…
…
continue reading
1
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.
5:10
5:10
Play later
Play later
Lists
Like
Liked
5:10
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique blood test identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal health. Speaker 3: (00:32) Can you share a little about yourself and your background? Speaker 3: (01:00) C…
…
continue reading
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., and Rondell Graham, M.B.B.S., delve into the critical decisions involved in contemplating a role on the staff at the institution where you receive your training. Timestamps: 00:00 Introduction 01:25 Why did you decide to take a job at the institution where you finished training? 0…
…
continue reading
1
Evolution of Syphilis: Elitza Theel, Ph.D.
13:03
13:03
Play later
Play later
Lists
Like
Liked
13:03
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to talk about the sexually-transmitted disease syphilis. Specific topics of discussion include: The history, cause…
…
continue reading
1
A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D.
11:42
11:42
Play later
Play later
Lists
Like
Liked
11:42
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to welcome the new year and discuss the increase of respiratory viruses. Their discussion includes: The increasing number of COV…
…
continue reading
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., engages in a compelling conversation with Lindsey Randall, a third-year medical student, as they discuss her experiences and insights in the role of a teaching assistant. 00:00 Introduction 01:05 Why did you decide to get involved in teaching in the first place? 02:07 You’ve been …
…
continue reading
1
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.
8:41
8:41
Play later
Play later
Lists
Like
Liked
8:41
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk. Show notes (00:31) Could you provide us a little bit about your background? (01:20) Could yo…
…
continue reading
1
Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.
7:10
7:10
Play later
Play later
Lists
Like
Liked
7:10
Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these infections. Show notes Speaker 3: (00:32) Please give us a brief introduction of yourself and your role at Mayo Clini…
…
continue reading
1
Unique testing helps identify cause of sudden cardiac death: Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC
13:24
13:24
Play later
Play later
Lists
Like
Liked
13:24
Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC, describe how Mayo Clinic Laboratories' postmortem genetic tests can provide answers after a sudden unexplained cardiac death. Test results are important for managing family members' risk for cardiovascular disease. Show notes (00:32) Would each of you share a little bit about yourselves and your b…
…
continue reading
1
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.
10:17
10:17
Play later
Play later
Lists
Like
Liked
10:17
Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage. Show notes (00:32) Could you please provide us a little information about your background? (01:46) Could you please give the …
…
continue reading
1
The Past, Present, and Future of Diagnostics: Bill Morice, M.D., Ph.D.
13:17
13:17
Play later
Play later
Lists
Like
Liked
13:17
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to reflect on key moments from 2023 and to discuss what may lie ahead in 2024. Their discussion includes: A look b…
…
continue reading
1
Assay identifies biomarker of autoimmune encephalitis subtype: Andrew McKeon, M.B., B.Ch., M.D.
17:42
17:42
Play later
Play later
Lists
Like
Liked
17:42
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' GABA-A receptor antibody assay aids diagnosis of this…
…
continue reading
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., along with the Lab Medicine Rounds podcast team share their experience on starting an educational podcast and reflecting on past episodes. Timestamps 00:00 Introduction 01:02 Rick: How did the podcast start up? What was the genesis, how did this all start? 03:05 Dr. Kreuter: How d…
…
continue reading
1
Milestone Treatments for Sickle Cell Disease: Bill Morice, M.D., Ph.D.
15:58
15:58
Play later
Play later
Lists
Like
Liked
15:58
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the U.S. Food and Drug Administration’s (FDA) recent approval of two gene therapies for sickle cell dis…
…
continue reading
1
Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D.
16:21
16:21
Play later
Play later
Lists
Like
Liked
16:21
Maria Willrich, Ph.D., and Melissa Snyder, Ph.D., describe Mayo Clinic Laboratories' panel for proactive therapeutic drug monitoring of patients with inflammatory bowel disease. The panel expands options for clinicians assessing patients' response to the drugs infliximab and adalimumab. (00:32) Could you provide a little bit of background informati…
…
continue reading